Pathfinder Cell Therapy, Inc.
Country not established
- Devices
- 1
What Pathfinder Cell Therapy, Inc. makes
Pathfinder Cell Therapy, Inc. manufactures the REPEL-CV bioresorbable adhesion barrier, a temporary implant designed to prevent postoperative adhesions in cardiovascular surgeries. The device is intended to reduce tissue fusion while degrading naturally over time without surgical removal.
The REPEL-CV bioresorbable adhesion barrier is classified as a Class III medical device under FDA regulations and is authorised through a Premarket Approval (PMA) application. The company is based in the United States.
Catalogue
Repel-Cv Bioresorbable Adhesion Barrier Ref P070005
Regimes: PMA, withdrawn Registry: PMA
Frequently asked questions
How many devices does Pathfinder Cell Therapy, Inc. have in the registry?
The registry currently lists 1 device for Pathfinder Cell Therapy, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Pathfinder Cell Therapy, Inc.'s devices?
Among its 1 most recently registered device, Pathfinder Cell Therapy, Inc. has devices listed in FDA PMA (1 device).
What risk classes do Pathfinder Cell Therapy, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Pathfinder Cell Therapy, Inc.'s devices are Class III. Each device page shows its own class and authorisation.
What are the newest devices from Pathfinder Cell Therapy, Inc. in the registry?
The most recently registered devices listed for Pathfinder Cell Therapy, Inc. include REPEL-CV BIORESORBABLE ADHESION BARRIER.